Literature DB >> 2041857

Bilateral papillitis with anti-neutrophil cytoplasmic antibodies associated with coeliac disease.

D Chan-Lam1, V Balasubramanian, R B Hogg.   

Abstract

A 39 year old woman with untreated coeliac disease presented with some of its complications and bilateral papillitis. She was found to have antineutrophil cytoplasmic antibodies (ANCA) in high titres. Following institution of gluten-free diet the complications resolved. The papillitis, however, persisted and needed a course of prednisolone to resolve, and a fall in the ANCA titres was noted. We believe that this is the first report of an association of coeliac disease and ANCA.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2041857      PMCID: PMC2398969          DOI: 10.1136/pgmj.67.784.206

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  5 in total

1.  Coeliac disease: a cause of various associated diseases?

Authors:  B B Scott; M S Losowsky
Journal:  Lancet       Date:  1975-11-15       Impact factor: 79.321

2.  Anticytoplasmic autoantibodies: their immunodiagnostic value in Wegener granulomatosis.

Authors:  B Nölle; U Specks; J Lüdemann; M S Rohrbach; R A DeRemee; W L Gross
Journal:  Ann Intern Med       Date:  1989-07-01       Impact factor: 25.391

3.  Arthritis and coeliac disease.

Authors:  J T Bourne; P Kumar; E C Huskisson; R Mageed; D J Unsworth; J A Wojtulewski
Journal:  Ann Rheum Dis       Date:  1985-09       Impact factor: 19.103

4.  Neurological disorders and adult coeliac disease.

Authors:  J S Morris; A B Ajdukiewicz; A E Read
Journal:  Gut       Date:  1970-07       Impact factor: 23.059

5.  Cutaneous vasculitis complicating coeliac disease.

Authors:  S Meyers; S Dikman; H Spiera; N Schultz; H D Janowitz
Journal:  Gut       Date:  1981-01       Impact factor: 23.059

  5 in total
  1 in total

Review 1.  Neurological complications of enteric disease.

Authors:  A Wills; C J Hovell
Journal:  Gut       Date:  1996-10       Impact factor: 23.059

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.